December 1, 2001Journal of the Royal Society of MedicineOpen Access

Nephrotoxicity in the Elderly Due to Co-Prescription of ACE Inhibitors and NSAIDs

View Full Paper

Ask AI

Bookmark

Population

Elderly heart failure patients

Design

Editorial

Authors

OJOscar M.P. JolobeBritish Medical Association

Discussion

Member takes

Implication

Highlights the significant risk of nephrotoxicity and hyperkalemia when co-prescribing ACE inhibitors, spironolactone, and NSAIDs in elderly heart failure patients.

Structured PICO

Population

Elderly heart failure patients

Intervention

Co-prescription of ACE inhibitors, spironolactone, and NSAIDs (including COX-2 inhibitors)

Highlights the significant risk of nephrotoxicity and hyperkalemia when co-prescribing ACE inhibitors, spironolactone, and NSAIDs in elderly heart failure patients.

Cite This Study

Oscar M.P. Jolobe (2001) studied this question.

synapsesocial.com/papers/6a90f477c39ca0eda1830235 https://doi.org/10.1177/014107680109401228

View Full Paper

Ask AI

Bookmark

Implication

Highlights the significant risk of nephrotoxicity and hyperkalemia when co-prescribing ACE inhibitors, spironolactone, and NSAIDs in elderly heart failure patients.

Nephrotoxicity in the Elderly Due to Co-Prescription of ACE Inhibitors and NSAIDs

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Nephrotoxicity in the Elderly Due to Co-Prescription of ACE Inhibitors and NSAIDs

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider